Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy.

Lee K, Nguyen V, Lee KM, Kang SM, Tang Q.

Am J Transplant. 2014 Jan;14(1):27-38. doi: 10.1111/ajt.12509.

2.

CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance.

Montane J, Obach M, Alvarez S, Bischoff L, Dai DL, Soukhatcheva G, Priatel JJ, Hardenberg G, Levings MK, Tan R, Orban PC, Verchere CB.

Cell Transplant. 2015;24(10):2143-54. doi: 10.3727/096368914X685249.

PMID:
26423995
3.

Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.

Velásquez-Lopera MM, Eaton VL, Lerret NM, Correa LA, Decresce RP, García LF, Jaramillo A.

Transpl Immunol. 2008 May;19(2):127-35. doi: 10.1016/j.trim.2008.02.003.

PMID:
18503888
4.

Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice.

Shi Q, Lees JR, Scott DW, Farber DL, Bartlett ST.

Am J Transplant. 2012 May;12(5):1124-32. doi: 10.1111/j.1600-6143.2011.03943.x.

5.

Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.

Deng R, Khattar M, Xie A, Schroder PM, He X, Chen W, Stepkowski SM.

Transplantation. 2014 Jun 27;97(12):1216-24. doi: 10.1097/TP.0000000000000120.

PMID:
24854475
6.

Novel sphingosine-1-phosphate receptor modulator KRP203 combined with locally delivered regulatory T cells induces permanent acceptance of pancreatic islet allografts.

Khattar M, Deng R, Kahan BD, Schroder PM, Phan T, Rutzky LP, Stepkowski SM.

Transplantation. 2013 Apr 15;95(7):919-27. doi: 10.1097/TP.0b013e3182842396.

7.

Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model.

Wu DC, Hester J, Nadig SN, Zhang W, Trzonkowski P, Gray D, Hughes S, Johnson P, Wood KJ.

Transplantation. 2013 Oct 27;96(8):707-16. doi: 10.1097/TP.0b013e31829fa271.

8.

Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts.

Brennan TV, Tang Q, Liu FC, Hoang V, Bi M, Bluestone JA, Kang SM.

J Surg Res. 2011 Jul;169(1):e69-75. doi: 10.1016/j.jss.2011.03.021.

9.
11.

Induction of tolerance and prolongation of islet allograft survival by syngeneic hematopoietic stem cell transplantation in mice.

Yang SF, Xue WJ, Lu WH, Xie LY, Yin AP, Zheng J, Sun JP, Li Y.

Transpl Immunol. 2015 Oct;33(2):130-9. doi: 10.1016/j.trim.2015.08.004.

PMID:
26311302
12.

Infiltrating Foxp3(+) regulatory T cells from spontaneously tolerant kidney allografts demonstrate donor-specific tolerance.

Hu M, Wang C, Zhang GY, Saito M, Wang YM, Fernandez MA, Wang Y, Wu H, Hawthorne WJ, Jones C, O'Connell PJ, Sparwasser T, Bishop GA, Sharland AF, Alexander SI.

Am J Transplant. 2013 Nov;13(11):2819-30. doi: 10.1111/ajt.12445.

13.

Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells.

Francis RS, Feng G, Tha-In T, Lyons IS, Wood KJ, Bushell A.

Eur J Immunol. 2011 Mar;41(3):726-38. doi: 10.1002/eji.201040509.

14.

Infusion of Lin- bone marrow cells results in multilineage macrochimerism and skin allograft tolerance in minimally conditioned recipient mice.

Anam K, Amare MF, Zins SR, Davis TA.

Transpl Immunol. 2010 Oct;24(1):69-75. doi: 10.1016/j.trim.2010.10.003.

PMID:
20950686
15.

Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.

Saborio DV, Chowdhury NC, Jin MX, Chandraker A, Sayegh MH, Oluwole SF.

Cell Transplant. 1999 Jul-Aug;8(4):375-81.

PMID:
10478717
16.

Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-gamma or IL-4.

Nicolls MR, Coulombe M, Yang H, Bolwerk A, Gill RG.

J Immunol. 2000 Apr 1;164(7):3627-34.

17.

Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts.

Nishihara M, Gotoh M, Ohzato H, Ohta Y, Luo Z, Dono K, Umeshita K, Sakon M, Monden M, Yagita H, Okumura K, Miyasaka M.

Transplantation. 1997 Oct 15;64(7):965-70.

PMID:
9381542
18.

Therapeutic efficacy of polyclonal tregs does not require rapamycin in a low-dose irradiation bone marrow transplantation model.

Pilat N, Klaus C, Gattringer M, Jaeckel E, Wrba F, Golshayan D, Baranyi U, Wekerle T.

Transplantation. 2011 Aug 15;92(3):280-8. doi: 10.1097/TP.0b013e3182241133.

PMID:
21697774
19.

Immature syngeneic dendritic cells potentiate tolerance to pancreatic islet allografts depleted of donor dendritic cells in microgravity culture condition.

Stepkowski SM, Phan T, Zhang H, Bilinski S, Kloc M, Qi Y, Katz SM, Rutzky LP.

Transplantation. 2006 Dec 27;82(12):1756-63.

PMID:
17198272
20.

Indefinite mouse heart allograft survival in recipient treated with CD4(+)CD25(+) regulatory T cells with indirect allospecificity and short term immunosuppression.

Tsang JY, Tanriver Y, Jiang S, Leung E, Ratnasothy K, Lombardi G, Lechler R.

Transpl Immunol. 2009 Sep;21(4):203-9. doi: 10.1016/j.trim.2009.05.003.

PMID:
19446634

Supplemental Content

Support Center